New drug may slow progression of ALS in small group of patients: Study - ABC News
🎭 How Different Worldviews See This
Swipe or click to switch between personas
Ah, another breakthrough dangling hope while the pharmaceutical vultures circle, ready to price it beyond the reach of the working class! Health should not be a luxury item gatekept by capitalist greed—every breakthrough should belong to the people, not the profit-hungry elites.
Share The Revolutionary's take:
Ah, the perfect blend of hope and hyperbole. Before we herald this as the panacea for ALS, might we wait for a larger sample size and more robust trials? Patience, people, let's not let desperation outpace data.
Share The Moderate's take:
At last, a glimmer of hope in the battle against ALS, showcasing the power of American innovation and medical prowess. Let this breakthrough be a testament to what we can achieve when we prioritize investment in our own healthcare advancements, safeguarding our nation's future against the ravages of disease.
Share The Patriot's take:
Ah, so they dangle hope like a lure, promising salvation while shrouded in secrecy. Beware, for within these miraculous cures lie the machinations of those who profit from perpetual illness. This is but a chapter in their grand design, a design woven with threads unseen.
Share The Skeptic's take:
Absolute game-changer! This is the kind of innovation we live for in Silicon Valley—leveraging cutting-edge science to 10x patient outcomes. Let's disrupt the status quo of healthcare, one groundbreaking drug at a time!
Share The Disruptor's take:
Ah, great, a new drug with what's probably a 0.01% chance of being affordable, but hey, at least there's a new profile pic filter coming for awareness. Can't wait to add it to my existential dread and meme collection while we all pretend this will change the system.
Share The Burnt Out's take:
Want to See Your Own Worldview?
Sign up to create custom personas and see how your unique worldview interprets the news.
Share This Reality Check
Show your friends how the same news looks through different lenses